Forta
Madalina C. serves as the Director of Scientific Research and Intellectual Property at Forta since April 2022, managing collaborations across Research and Development teams to develop machine learning-based clinical solutions resulting in FDA submissions, patent applications, and research publications. Prior to this role, Madalina worked at Conley Rose, P.C. in various capacities, including Technical Advisor and Independent Contractor, focusing on patent application prosecution in multiple technical fields. With a comprehensive academic background, including a Ph.D. in Analytical Chemistry from the University of Memphis and extensive research experience at institutions like Vanderbilt University and the University of Colorado Denver, Madalina has contributed significantly to scientific advancements in cancer research and patent strategy.
This person is not in any offices
Forta
2 followers
Forta is clearing the path to quality healthcare. We continuously improve the patient journey and deliver personalized care by applying AI and machine learning. The first care vertical Forta is improving is autism ABA therapy. Care is difficult to access and the delivery model must be reinvented to provide early access to families. 1 in 44 children [CDC, 2021] is diagnosed to be on the autism spectrum. We are looking for driven, innovative, patient-focused individuals to join our team as we reinvent the care and tools available to neurodiverse families.